Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-100
Closed -$18.5K – 10334
2022
Q4
$18.5K Buy
+100
New +$17.6K ﹤0.01% 7735
2021
Q4
– Sell
-200
Closed -$41K – 10681
2021
Q3
$41K Buy
+200
New +$42.8K ﹤0.01% 6503
2021
Q1
– Sell
-200
Closed -$38K – 9440
2020
Q4
$38K Hold
200
– – ﹤0.01% 6429
2020
Q3
$35K Hold
200
– – ﹤0.01% 5891
2020
Q2
$31K Buy
+200
New +$30.5K ﹤0.01% 6250

Other funds holding STE

UBS Group's STE Position: Q3 2026 in Review

UBS Group increased its Steris (STE) stake by 17% in Q3 2026, buying an estimated $15.3M and bringing the position to 466,002 shares worth $97.9M. The position accounts for 0.01% of the portfolio, ranked #1112.

UBS Group first reported a position in STE in Q4 2014 and has held it in 48 quarters since. The position peaked at $130M in Q4 2025. 820 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • UBS Group held 466,002 shares of Steris worth $97.9M as of Q3 2026.
  • UBS Group bought 69,001 Steris shares in Q3 2026, an estimated $15.3M.
  • Steris made up 0.01% of UBS Group's portfolio in Q3 2026, its #1112 holding.
  • UBS Group first reported a position in Steris in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Steris position peaked at $130M in Q4 2025.
  • 820 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.